| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―28 |
A rare case of development of lung gangrene with areas of disintegration after reinfection with SARS-CoV-2 |
O.V. Alpidovskaya |
| 2 |
[GO] |
2025―Feb―28 |
Features of the development and course of a new coronavirus infection against the background of combined autoimmune pathology |
Yu.A. Rogova, V.V. Kiseleva, L.V. Belokonova |
| 3 |
[GO] |
2025―Feb―28 |
Role of cytokine gene polymorphic variants in the COVID-19 course-dependent pathway |
N.I. Baranova, L.A. Aschina, A.I. Bolgova, O.N. Lesina |
| 4 |
[GO] |
2025―Feb―28 |
Indicators of hemostasis and fibrinolysis systems in patients with pulmonary tuberculosis and chronic viral hepatitis who underwent COVID-19 |
R.Yu. Abdullaev, O.G. Komissarova, V.A. Shorokhova, T.V. Kurmaeva |
| 5 |
[GO] |
2025―Feb―28 |
Underdiagnosed case of rhinocerebral mucormycosis in a patient who has experienced COVID-19 |
O.A. Lyubimtseva, K.P. Kuzmicheva, O.A. Rychkova |
| 6 |
[GO] |
2024―Oct―18 |
Dynamics of the incidence of occupational coronavirus infection COVID-19 and mortality from it of medical workers of healthcare institutions of the Federal Medical-Biological Agency of the Russian Federation |
A.R. Tukov, M.N. Ziyatdinov, A.S. Kretov, A.М. Mikhaylenko |
| 7 |
[GO] |
2024―Oct―18 |
Clinical case of multiple complications of pregnancy and puerperium in patient, infected COVID-19 |
A.V. Khardikov, I.S. Luneva, A.V. Borshchev |
| 8 |
[GO] |
2024―Oct―18 |
Analysis of the manifestations of the COVID-19 epidemic process in the territory of the Moscow agglomeration for the period 2020-2022 |
Yu.Yu. Grishina, Yu.V. Martynov, E.V. Kukhtevich, S.A. Mikhneva |
| 9 |
[GO] |
2024―Sep―06 |
Clinical case of combined course of focal pulmonary tuberculosis with secondary amyloidosis and COVID-19 |
O.V. Alpidovskaya |
| 10 |
[GO] |
2024―Sep―06 |
Clinical and laboratory characteristics of the new coronavirus infection (COVID-19) in adults, the dynamics of the disease |
Ya.V. Malikova, D.A. Valishin, R.T. Murzabaeva |
| 11 |
[GO] |
2024―Mar―29 |
Analysis of cytokine levels depending on the course of COVID-19 |
M.D. Akhmedova, T.A. Ruzhentsova, Ja.J. Janibekov, A.A. Ismailova, M.Kh. Maksudova, Ja.A. Anvarov |
| 12 |
[GO] |
2024―Mar―29 |
Analysis of linguistic techniques contributing to fear-mongering about COVID-19 (Omicron strain) from selected English news feeds |
A. Saleem, U. Tariq |
| 13 |
[GO] |
2024―Mar―29 |
Mortality from tuberculosis and HIV infection in the Kaluga region before and during the COVID-19 pandemic |
I.S. Lapshina, E.B. Tsybikova |
| 14 |
[GO] |
2024―Mar―29 |
Analysis of side effects during COVID-19 pharmacotherapy |
N.I. Baranova, L.A. Aschina |
| 15 |
[GO] |
2024―Mar―29 |
Lipid metabolism indicators in patients with SARS-CoV-2 infection |
N.A. Konyshko, L.I. Volynets, G.S. Konyshko |
| 16 |
[GO] |
2024―Jan―26 |
Evaluation of the inhaled immunosuppressants effectiveness in the treatment of COVID-19 |
V.I. Kobylyansky |
| 17 |
[GO] |
2024―Jan―26 |
Determination of total lactate dehydrogenase activity and the ratio of isotypes for predicting the severity of the course and diagnosis of organ lesions in COVID-19 |
R.F. Sayfullin, S.K. Pylaeva, N.F. Frolova, D.O. Sinyavkin, D.A. Baykov |
| 18 |
[GO] |
2024―Jan―26 |
The frequency of deaths from COVID-19 among vaccinated and unvaccinated individuals |
C. Zhang, S.R. Raicic, E.G. Simonova, I.A. Khrapunova, M.P. Kostinov |
| 19 |
[GO] |
2024―Jan―26 |
Course and outcomes of COVID-19 in hospitalized patients, considering the level of lymphopenia |
T.A. Botabaev, Ya.S. Ulyanova, E.I. Krasnova, L.L. Pozdnyakova, N.I. Khokhlova |
| 20 |
[GO] |
2024―Jan―26 |
Effectiveness of influenza vaccination in the context of the COVID-19 pandemic (material for preparing the lecture) |
M.P. Kostinov, S.Yu. Tyukavkina, G.G. Kharseeva, N.Yu. Nastaeva |
| 21 |
[GO] |
2024―Jan―26 |
Association between blood glucose levels and other comorbidities with outcomes of COVID-19 patients in a tertiary care hospital |
K. Poorani, SriL. A. Naveen, V. Sandhiya, B. Dhanashree, R. Karthikeyan, А. Murali, S. Ramalingam |
| 22 |
[GO] |
2024―Jan―26 |
Features of cytokine status dynamics in patients with COVID-19 using Ambervin® Pulmo |
O.A. Radaeva, L.A. Balykova, N.A. Pyataev, K.Y. Zaslavskaya, Yu.A. Kostina, V.V. Eremeev, et al. (+2) A.V. Taganov, P.A. Belyy |
| 23 |
[GO] |
2024―Jan―26 |
The debut of hereditary neurodegenerative disease on the background of addition of coronavirus infection |
A.O. Mikhailov, I.V. Ubozhenko, S.A. Sokotun, L.V. Rodionova |
| 24 |
[GO] |
2024―Jan―26 |
Development of a reagent kit for the detection of SARS-CoV-2 virus RNA using real-time reverse transcription polymerase chain reaction |
A.V. Kazantsev, Ya.I. Alekseev, O.V. Chuhralya, D.A. Varlamov, N.V. Karulina, T.E. Sizikova, et al. (+9) D.I. Pavel'ev, A.A. Petrov, A.V. Manoshkin, A.V. Kuzubov, S.N. Khmurenko, V.N. Lebedev, D.A. Kutaev, D.G. Melnikov, S.V. Borisevich |
| 25 |
[GO] |
2024―Jan―26 |
Long-term cytokine content in children with SARS-CoV-2-associated multisystem inflammatory syndrome in comparison with the initial period of the disease |
O.O. Obukhova, T.I. Ryabichenko, G.A. Skosyreva, O.M. Gorbenko, A.O. Izumov, T.V. Kartseva, M.I. Voevoda |
| 26 |
[GO] |
2023―Oct―09 |
The neuropilin-1 content in the serum of patients with community-acquired pneumonia and COVID-19 |
D.A. Dyakov, O.E. Akbasheva, L.V. Spirina, I.Yu. Shuvalov, A.E. Kebekbayeva, V.N. Masunov, N.V. Masunova |
| 27 |
[GO] |
2023―Oct―09 |
Features of management of patients with COVID-19 and secondary immunodeficiency in real clinical practice |
V.P. Sereda, K.A. Tikhonova, I.S. Moroz, A.M. Tuktarov |
| 28 |
[GO] |
2023―Oct―09 |
Variability of time trends of glycemia and outcomes of COVID-19 associated pneumonia in patients with comorbid diseases |
E.Yu. Soloveitchik, D.A. Valishin, M.G. Davydovich, P.I. Mironov, A.R. Shakirov, I.I. Lutfarakhmanov |
| 29 |
[GO] |
2023―Oct―09 |
COVID-19 epidemic process in the Russian Federation: determinants and manifestations |
T.A. Platonova, A.A. Golubkova, S.S. Smirnova, V.А. Mishchenko, M.S. Sklyar, E.A. Karbovnichaya, et al. (+5) K.V. Varchenko, K.S. Komissarova, A.B. Komissarov, D.A. Lioznov, A.V. Semenov |
| 30 |
[GO] |
2023―Oct―09 |
Possibilities for early prediction of COVID-19 outcomes in hospitalized patients |
N.A. Ilina, T.M. Klimova, S.S. Sleptsov, S.S. Sleptsovа |
| 31 |
[GO] |
2023―Oct―09 |
The incidence of tuberculosis in Russian Federation before and during the COVID-19 pandemic |
V.I. Starodubov, E.B. Tsybikova, M.Yu. Kotlovskiy, I.S. Lapshina |
| 32 |
[GO] |
2023―Oct―09 |
The effectiveness of the combined use of specific and nonspecific COVID-19 preventive measures |
I.V. Feldblum, T.M. Repin, M.Y. Devyatkov, M.A. Gileva, A.A. Kovtun |
| 33 |
[GO] |
2023―Oct―09 |
Revaccination against COVID-19: the current state of the problem (lecture preparation material) |
M.P. Kostinov, N.P. Andreeva, S.R. Raicic, A.M. Kostinova |
| 34 |
[GO] |
2023―Aug―28 |
The incidence of occupational coronavirus infection COVID-19 in medical workers of healthcare institutions of the FMBA of Russia |
A.R. Tukov, A.S. Kretov, A.A. Vyunova, I.V. Vlasova |
| 35 |
[GO] |
2023―Aug―28 |
On the need and peculiarities of vaccination against COVID-19 in patients with neurological disorders |
S.R. Raicic, M.P. Kostinov, E.G. Simonova, G.G. Kharseeva |
| 36 |
[GO] |
2023―Aug―28 |
Features of COVID-19 pathogenesis (to help the lecturer) |
A.B. Khaitovich, P.A. Yermachkova |
| 37 |
[GO] |
2023―Mar―23 |
Multisystem inflammatory syndrome associated with COVID-19 in adult: the case report |
I.Kh. Belyaletdinova, M.A. Sayfullin, G.D. Guseva, N.E. Perekopskaya |
| 38 |
[GO] |
2023―Mar―23 |
Personalized approach to the management of a patient with COVID-19 with a complicated comorbid background |
S.A. Chepurnenko, G.V. Shavkuta, N.M. Bulgakova, A.V. Safonova |
| 39 |
[GO] |
2023―Mar―23 |
Online survey results among social network users in terms of the COVID-19 problem |
A.R. Tyapayeva, E.A. Naumova, O.N. Semenova |
| 40 |
[GO] |
2023―Mar―23 |
Impact of anti-epidemic measures on the dynamics of the incidence of COVID-19 in medical organizations with a psychoneurological profile |
M.A. Godkov, V.A. Gushchin, A.N. Tsibin, V.V. Shustov, E.A. Kasholkina |
| 41 |
[GO] |
2023―Mar―23 |
Features of inflammatory periodontal diseases course in combination with a new coronavirus disease. A systematic review |
N.R. Evarnitskaya, O.O. Yanushevich |
| 42 |
[GO] |
2023―Feb―06 |
Study of cases of Pseudomonas aeruginosa bacteria in patients with severe COVID-19 |
A.S. Malygin, M.A. Lysenko, S.V. Tsarenko, E.V. Filimonova |
| 43 |
[GO] |
2023―Feb―06 |
Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19 |
E.V. Tavlueva, A.E. Markarov, M.A. Petrushin, A.A. Vizel, G.L. Ignatova, V.N. Antonov, et al. (+7) A.S. Agaf'ina, B.A. Bakirov, V.M. Mozgovaya, O.V. Filon, A.V. Zinkovskaya, A.N. Dolgorukova, M.Yu. Samsonov |
| 44 |
[GO] |
2023―Feb―06 |
Trace elements: role in the development of severe forms of COVID-19 and the possibility of correction |
A.O. Romanov, M.M. Sharipova, I.A. Popova, A.N. Arkhangelskaia, K.G. Gurevich, N.L. Shimanovskiy |
| 45 |
[GO] |
2023―Feb―06 |
Prognostic criteria for the development of severe clinical forms of COVID-19 in medical organization workers |
T.A. Platonova, T.A. Semenenko, A.A. Golubkova, E.I. Sisin, M.S. Sklyar, E.A. Karbovnichaya, S.S. Smirnova |
| 46 |
[GO] |
2023―Feb―06 |
Clinical and laboratory manifestations and pathological anatomical picture of a severe course of a new coronavirus infection COVID-19 with a fatal outcome |
R.Yu. Abdullaev, O.G. Komissarova, M.M. Rybka, E.M. Greсov, L.A. Semenova, Yu.S. Berezovsky |
| 47 |
[GO] |
2023―Feb―06 |
Approaches to vaccination against coronavirus infection in patients with autoimmune inflammatory rheumatic diseases |
A.A. Tarasova, M.P. Kostinov, M.A. Kvasova |
| 48 |
[GO] |
2023―Feb―06 |
The use of neutralizing monoclonal antibodies against SARS-CoV-2 in hemodialysis patients |
E.V. Volodina, N.F. Frolova, M.A. Lysenko, I.G. Kim, A.I. Ushakova, V.E. Vinogradov, et al. (+6) S.S. Usatiuk, A.M. Nikitina, U.A. Markina, V.I. Chervinko, E.V. Kryukov, M.L. Zubkin |
| 49 |
[GO] |
2023―Feb―06 |
Infectious mononucleosis combined with SARS-CoV-2 infection |
T.I. Kalenchic, S.L. Kabak, A.U. Rysevets |
| 50 |
[GO] |
2022―Nov―14 |
Polymorphism of genes in patients with new coronavirus infection COVID-19 |
B.I. Kantemirova, V.V. Vasilkova |
| 51 |
[GO] |
2022―Nov―14 |
Efficiency of application of sorbed probiotics in the complex therapy of pneumonia caused by SARS-CoV-2. Quality of life in the short term COVID-19 |
E.R. Meskina, M.K. Khadisova, T.V. Stashko, L.A. Galkina, E.E. Tselipanova, I.M. Shilkina |
| 52 |
[GO] |
2022―Nov―14 |
The effect of etiotropic therapy on the formation of immune disorders in patients with COVID-19 |
E.P. Tikhonova, A.A. Savchenko, T.A. Yelistratova, Yu.S. Kalinina, T.Yu. Kuz'mina, E.V. Kasparov, et al. (+3) V.D. Belenyuk, I.S. Sadovsky, A.G. Borisov |
| 53 |
[GO] |
2022―Nov―14 |
The features of the liver function tests in patients with COVID-19 |
V.K. Fazylov, A.F. Oleynik, O.F. Abdullah, V.O. Akifiev, A.М. Fayyadh, G.C. Revathy |
| 54 |
[GO] |
2022―Nov―14 |
Features of the diagnosis and course of COVID-19 in HIV-infected patients hospitalized in a hospital |
A.S. Sycheva, M.V. Nagibina, K.A. Uryanskaya, A.A. Solodov, A.L. Kebinа, I.V. Semeniakin, et al. (+2) O.V. Levchenko, O.O. Yanushevich |
| 55 |
[GO] |
2022―Nov―14 |
Features of the COVID-19 in lung tissue damage admitted to hospital |
L.V. Povalyaeva, E.S. Vdoushkina, E.A. Borodulina, E.V. Yakovleva, Zh.P. Vasneva, A.N. Gerasimov, A.E. Sukhanova |
| 56 |
[GO] |
2022―Nov―14 |
Description of the clinical picture of COVID-19 in patients with fatal outcome |
L.V. Ter-Bagdasaryan, L.I. Ratnikova, E.Yu. Lebedeva, G.V. Sychugov, A.V. Ivanova, D.V. Pirogov, et al. (+2) K.A. Nikulina, M.A. Lokteva |
| 57 |
[GO] |
2022―Nov―14 |
Vaccination against COVID-19 in patients with inflammatory bowel diseases |
A.A. Khasanova, M.P. Kostinov, I.L. Soloveva, A.P. Cherdantsev |
| 58 |
[GO] |
2022―Nov―14 |
Survey of medical university staff: assessment of COVID-19 manifestations in periods of peak and convalescence |
O.O. Yanushevich, E.N. Yushchuk, N.S. Smetneva, O.V. Levchenko, A.I. Machulina |
| 59 |
[GO] |
2022―Nov―14 |
Antibiotic therapy of Acinetobacter baumannii bloodstream infection in COVID-19 patients |
A.S. Malygin, S.V. Tsarenko, E.V. Filimonova |
| 60 |
[GO] |
2022―Nov―14 |
Clinical experience of Raphamin therapy in outpatients after hospital treatment of COVID-19 pneumonia |
A.V. Mordyk, L.V. Puzyreva, E.P. Antipova, A.V. Verbanov |
| 61 |
[GO] |
2022―Nov―14 |
A study on COVID-19 vaccine hesitancy among healthcare professionals in India |
Sree T. Sucharitha, E. Premalatha, C. Chakrapani, T.K.V. Saravanan, R. Lakshmi |
| 62 |
[GO] |
2022―Jul―28 |
Clinical and immunological parallels in children patients with COVID-19 |
O.O. Obukhova, G.S. Karpovich, T.I. Ryabichenko, G.A. Skosyreva, O.M. Gorbenko, A.N. Trunov, et al. (+2) I.V. Kuimova, M.I. Voevoda |
| 63 |
[GO] |
2022―Jul―28 |
Clinical manifestations and emotional disorders in patients with new coronavirus infection (COVID-19) |
L.I. Ratnikova, V.G. Ragozinskaya |
| 64 |
[GO] |
2022―Jul―28 |
Clinical and laboratory characteristics of new coronaviral infection (COVID-19) in children |
A.A. Khasanova, M.P. Kostinov, I.L. Soloveva, A.P. Cherdantsev |
| 65 |
[GO] |
2022―Jul―28 |
Clinical and laboratory characteristics of new coronaviral infection (COVID-19) in children |
R.T. Murzabaeva, D.A. Valishin, N.A. Abrashina, L.V. Murzagaleeva, A.D. Valishina |
| 66 |
[GO] |
2022―Jul―28 |
Evaluation of clinical outcomes of COVID-19 in patients taking remdesivir in complex therapy in routine clinical practice |
M.V. Zhuravleva, E.V. Kuznetsova, T.R. Kameneva, A.N. Kulikov, E.D. Laryushkina, O.M. Romashov, et al. (+9) S.S. Andreev, M.A. Ivzhits, E.V. Zernova, S.D. Mitrokhin, T.V. Bikbaeva, A.P. Filatova, A.V. Kryukov, A.A. Khokhlov, I.D. Abusev |
| 67 |
[GO] |
2022―Jul―28 |
Mechanisms of olfactory impairment in COVID-19: a systematic review |
A.R. Medeulova, K.A. Zhapar, D.G. Kussainova |
| 68 |
[GO] |
2022―Mar―30 |
Validation of the russian version of the 4C Mortality Score and prediction of outcomes of severe COVID-19 |
V.I. Vechorko, O.V. Averkov, N.A. Suponeva, M.A. Piradov, A.A. Zimin, Ja.G. Yusupova, et al. (+8) A.B. Zaitsev, D.V. Grishin, N.V. Polekhina, A.V. Naminov, N.M. Ramchandani, S.R. Knight, M.G. Semple, E.M. Harrison |
| 69 |
[GO] |
2022―Mar―30 |
Prevention of COVID-19 coronavirus infection with aminodihydrophthalazinedione sodium (Galavit®) in medical staff of the “red zone”: results of the multicenter observational study |
S.V. Kolesov, M.E. Mozheyko, G.S. Trufanov, D.S. Gorbatyuk |
| 70 |
[GO] |
2022―Mar―30 |
Some clinical and epidemiological aspects of the course of COVID-19 in people living with HIV |
N.N. Dolgova, A.A. Ryndich, A.G. Suladze, T.I. Tverdokhlebova, A.N. Matuzkova, K.Kh. Bolatchiev, L.F. Chernigovec |
| 71 |
[GO] |
2022―Mar―30 |
Listeriosis and the COVID-19 pandemic |
E.А. Klimova, O.L. Voronina, G.N. Karetkina, E.A. Posukhovsky, N.N. Ryzhova, M.S. Kunda, et al. (+12) E.I. Aksenova, A.V. Kutuzova, T.I. Karpova, I.S. Tartakovskiy, A.Yu. Pokidysheva, T.V. Pronina, A.R. Melkumyan, O.E. Orlova, E.N. Burmistrova, A.A. Syrochev, S.V. Smetanina, N.D. Yushchuk |
| 72 |
[GO] |
2022―Mar―30 |
Preliminary analysis of the epidemiological effectiveness of COVID-19 vaccination in the Saratov Region |
A.N. Danilov, T.L. Abramyan, I.A. Mamonova, I.E. Irishkova, D.A. Teisherskaya |
| 73 |
[GO] |
2022―Mar―30 |
COVID-19: the efficacy and safety of anticoagulant, glucocorticosteroid therapy and metabolic |
D.P. Salivonchyk, I.О. Stoma, E.A. Dotsenko, N.N. Kudenchuk, E.I. Salivonchyk, I.A. Khudyakov, et al. (+7) M.N. Menshakova, E.I. Malashchenko, S.D. Salivonchyk, K.O. Bondareva, E.A. Stepanets, O.V. Konovalova, E.V. Kuhoreva |
| 74 |
[GO] |
2022―Mar―30 |
Determination of antibodies to SARS-CoV-2 in patients with coronavirus infection |
G.M. Ignatyev, L.I. Kozlovskaya, K.M. Mefed, V.P. Volok, I.Kh. Belyaletdinova, A.A. Erovichenkov, et al. (+8) D.M. Danilenko, N.L. Aleshenko, S.A. Klotchenko, N.L. Maksimov, E.K. Atremov, A.N. Piniaeva, D.A. Lioznov, A.A. Ishmukhametov |
| 75 |
[GO] |
2022―Mar―30 |
Features of the course and medical and social aspects of a new coronavirus infection in the Republic of Tajikistan |
Ja.A. Abdullozoda, J.Yu. Salomudin, R.A. Tursunov |
| 76 |
[GO] |
2022―Mar―30 |
Results of screening examination of employees of a medical hospital for antibodies to SARS-CoV-2 |
R.F. Sayfullin, S.K. Pylaeva, D.O. Sinyavkin |
| 77 |
[GO] |
2021―Dec―23 |
The use of enterosorbents in the immunorehabilitation of patients who have had a new coronavirus infection COVID-19 |
E.P. Tikhonova, A.A. Savchenko, T.Yu. Kuz'mina, Yu.S. Kalinina, N.A. Dyachenko, A.A. Masterova, et al. (+3) V.D. Belenyuk, A.G. Borisov, M.A. Popilov |
| 78 |
[GO] |
2021―Dec―23 |
The therapeutics, based on virus specific antibodies, for special prophylactic and current of COVID-19 |
T.E. Sizikova, E.V. Lebedinskaya, V.N. Lebedev, S.V. Borisevich |
| 79 |
[GO] |
2021―Dec―23 |
Markers of acute inflammation in patients with COVID-19 in combination with hypertension |
V.V. Kiseleva, K.S. Yachmenev, L.Yu. Zaitseva |
| 80 |
[GO] |
2021―Dec―23 |
Overview of the "Partnership against the pandemic session: anti-crisis strategies in medicine" within the framework of the Eastern Economic Forum "New opportunities of the Far East in a changing world" |
G.E. Ulumbekova |
| 81 |
[GO] |
2021―Oct―04 |
Analysis of deaths during the first wave of a new coronavirus infection - COVID-19 |
R.A. Tursunov, D.A. Olimov, G.M. Khojamuradov |
| 82 |
[GO] |
2021―Oct―04 |
Analysis data of mechanism of drugs recommended for the treatment of COVID-19 |
O.A. Radaeva, Yu.A. Kostina |
| 83 |
[GO] |
2021―Oct―04 |
Antibiotic resistance of Klebsiella pneumoniae against the background of the COVID-19 pandemic: experience of the multidisciplinary hospital |
D.V. Tapalski, E.V. Karpova, O.M. Akulenok, V.K. Okulich, I.I. Generalov, N.Yu. Leskova, et al. (+5) E.G. Antonova, I.V. Zhiltsov, O.V. Osipkina, L.V. Mozharovskaya, O.Yu. Baranov |
| 84 |
[GO] |
2021―Oct―04 |
Economic aspects of COVID-19 treatment in a hospital setting |
E.A. Zhidkova, R.I. Shaburov, S.V. Cheremushkin, A.V. Gubkin, I.V. Rogova, I.A. Popova, K.G. Gurevich |
| 85 |
[GO] |
2021―Oct―04 |
Analysis of clinical cases of new coronavirus infection in patients with a history of heart transplantation |
V.V. Kiseleva, N.S. Kolupaev, Yu.A. Rogova |
| 86 |
[GO] |
2021―Oct―04 |
Frequency of SARS-CoV-2 infection in hemodialysis patients |
M.L. Zubkin, V.Yu. Shilo, L.I. Novikova, O.Yu. Borisova, I.G. Kim, S.S. Bochkareva, et al. (+7) L.A. Dragina, O.B. Rybakova, N.V. Gudova, E.V. Volodina, V.I. Chervinko, N.A. Tomilina, E.V. Kryukov |
| 87 |
[GO] |
2021―Jul―02 |
Morphofunctional changes in the conducting and respiratory parts of the bronchopulmonary system in COVID-19 (analytical review) |
V.I. Kobylyansky |
| 88 |
[GO] |
2021―Jul―02 |
Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale |
E.V. Kryukov, D.V. Cherkashin, I.A. Reutskiy, V.N. Solntsev, S.A. Bucenko, A.D. Sobolev, et al. (+4) B.V. Levankov, M.V. Dmitriev, S.V. Efimov, G.G. Kutelev |
| 89 |
[GO] |
2021―Jul―02 |
Retrospective analysis of risk factors for COVID-19 in the working population |
E.A. Zhidkova, E.M. Gutor, Yu.А. Tkachenko, I.V. Rogova, I.A. Popova, K.G. Gurevich |
| 90 |
[GO] |
2021―Mar―30 |
COVID-19 in hemodialysis patients |
N.F. Frolova, I.G. Kim, A.I. Ushakova, S.S. Usatiuk, L.Yu. Artyukhina, R.T. Iskhakov, et al. (+9) V.V. Varyasin, D.O. Sinyavkin, E.N. Diakova, K.E. Loss, V.I. Chervinko, E.V. Volodina, N.A. Tomilina, E.V. Kryukov, M.L. Zubkin |
| 91 |
[GO] |
2021―Feb―01 |
Efficacy and safety of favipiravir in a complex therapy of mild to moderate COVID-19 |
Tatiana A. Ruzhentsova, Pavel V. Chukhlyaev, Daria A. Khavkina, Alexander A. Garbuzov, Antonina A. Ploskireva, Rodion A. Oseshnyuk, et al. (+26) Tatyana N. Soluyanova, Irina V. Shestakova, Adel Yu. Vafin, Elena P. Dmitrikova, Dzhavanshir M. Mustafaev, Tatiana N. Domostroeva, Maria V. Otpushchennikova, Konstantin A. Pokrovskiy, Marina G. Rusanova, Dmitriy A. Bistritskiy, Тatyana N. Markova, Elena A. Kaplun, Diana V. Petina, Nataliya E. Kostina, Viсtoria S. Lesina, Sergey G. Shcherbak, Alina S. Agaf'ina, Yury F. Brook, Oleg Yu. Bronov, Evgeny I. Shults, Emilia N. Krasavina, Mikhail Yu. Samsonov, Arkadiy V. Zintchenko, Mariya V. Nikolskaya, Viсtoria A. Razzhivina, Olga V. Filon |
| 92 |
[GO] |
2021―Feb―01 |
Features of the steroid profile of saliva in patients with COVID-19 |
Svetlana Yu. Kalinchenko, Sergey Yu. Ivanov, Leonid L. Borozdkin, Roman A. Terushkin, Andrei A. Isaev, Artur R. Avetisyan, Aslan R. Shurmudov |
| 93 |
[GO] |
2021―Feb―01 |
Novel coronavirus disease (COVID-19) and cytokine storms. For more effective treatments from the viewpoints of an inflammatory pathophysiology perspective |
Shumpei Yokota, Yoshiyuki Kuroiwa, Kusuki Nishioka |
| 94 |
[GO] |
2021―Feb―01 |
Surgical care for adults on "urology" in the context of the COVID-19 pandemic |
Alexander O. Vasilyev, Vigen A. Malkhasyan, Gevorg R. Kasyan, Alexander V. Govorov, Lyubov A. Khodyreva, Konstantin B. Kolontarev, et al. (+2) Arseniy A. Shiryaev, Dmitry Y. Pushkar |
| 95 |
[GO] |
2020―Oct―08 |
New possibilities for targeted antiviral therapy for COVID-19. Results of a multi center clinical study of the efficacy and safety of using the drug Areplivir |
L.A. Balykova, M.V. Granovskaya, K.Y. Zaslavskaya, E.N. Simakina, A.S. Agaf'ina, A.Y. Ivanova, et al. (+2) K.B. Kolontarev, D.Y. Pushkar |
| 96 |
[GO] |
2020―Oct―08 |
Experience of the infectious service of the Republic of Saкha (Yakutia) during the pandemic of the new coronavirus infection |
S.S. Sleptsovа, E.A. Borisova, V.E. Tarasova, E.Yu. Malinnikova |
| 97 |
[GO] |
2020―Oct―08 |
Could influenza vaccination be a non-specific prevention of SARS-CoV-2 and other respiratory infections? |
M.P. Kostinov, E.A. Khromova, A.M. Kostinova |
| 98 |
[GO] |
2020―Jul―09 |
Modern representations of the new coronavirus and the disease caused by SARS-COV-2 |
M.P. Kostinov, A.D. Shmitko, V.B. Polishchuk, E.A. Khromova |
| 99 |
[GO] |
2020―Jul―09 |
The hypothesis of epidemic welfare for SARS-CoV-2 in Russia |
M.P. Kostinov |
| 100 |
[GO] |
2020―Jul―09 |
New coronaviral infection. Today’s look at the pandemic of the XXI century |
E.Yu. Malinnikova |
